Delivery Order SPE2DB20D1109-SPE2DB24FP52U

Award Date 7/18/24
Potential Completion Date 7/19/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,231.44 firm fixed-price delivery order is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, with a completion date of September 18, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,355.91 firm fixed-price delivery order is for the supply of 225 mg/1.5 ml AJOVY auto-injector products. The contract has an ultimate completion date of June 4, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,055.52 firm-fixed-price delivery order is for the supply of AJOVY 225 MG/1.5 ML syringes, a specialty medication. The contract has a period of performance through November 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML. The $3,206.04 firm fixed-price delivery order is a part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that runs through November 2026. This IDC enables efficient government procurement of essential pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,055.52 delivery order contract is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a prescription medication. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to AmerisourceBergen Drug Corp is for the delivery of the pharmaceutical product AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML. The $1,852.60 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $1,264.90 firm fixed price delivery order is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, with a completion date of June 13, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,507.19 contract is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a specialty medication, with a completion date of May 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,565,388,970 units of the pharmaceutical product AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML. The award has a ceiling value of $1,159.29 and an ultimate completion date of August 9, 2024. This delivery order contract is a firm-fixed-price arrangement and does not have a set-aside designation. Amerisourcebergen...
This federal contract award is a delivery order (SPE2DB20D2104|SPE2DB24FT85P) worth $1,581.52 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a specialty medication, with a completion date of April 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP52U
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,407.36 firm fixed-price delivery order is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, with a completion date of July 19, 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award was not designated with any set-aside requirements, indicating open competition.

Generated 2/27/25, 10:37 AM